CL2014003561A1 - Ácido nucleico infeccioso de virus torque teno porcino (pttv) que comprende secuencia que codifica un pttv infeccioso con una secuencia genómica de pttv 1b-va; ácido nucleico, plásmido y célula hospedera que la comprenden; pttv infeccioso no virulento; vacuna. - Google Patents

Ácido nucleico infeccioso de virus torque teno porcino (pttv) que comprende secuencia que codifica un pttv infeccioso con una secuencia genómica de pttv 1b-va; ácido nucleico, plásmido y célula hospedera que la comprenden; pttv infeccioso no virulento; vacuna.

Info

Publication number: CL2014003561A1
Authority: CL; Chile
Prior art keywords: pttv; infectious; nucleic acid; virulent; porcine
Prior art date: 2009-08-21

Application number

CL2014003561A

Other languages

English (en)

Inventor

Yaowei Huang

Xiang-Jin Meng

Original Assignee

Virginia Tech Intell Prop

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-08-21

Filing date

2014-12-29

Publication date

2015-04-24

2014-12-29 Application filed by Virginia Tech Intell Prop filed Critical Virginia Tech Intell Prop

2015-04-24 Publication of CL2014003561A1 publication Critical patent/CL2014003561A1/es

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—DNA viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/00034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/085—Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Biomedical Technology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
General Engineering & Computer Science (AREA)
Physics & Mathematics (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Analytical Chemistry (AREA)
Mycology (AREA)
Epidemiology (AREA)
Food Science & Technology (AREA)
Pathology (AREA)
Tropical Medicine & Parasitology (AREA)
Cell Biology (AREA)
General Physics & Mathematics (AREA)
Gastroenterology & Hepatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)

CL2014003561A 2009-08-21 2014-12-29 Ácido nucleico infeccioso de virus torque teno porcino (pttv) que comprende secuencia que codifica un pttv infeccioso con una secuencia genómica de pttv 1b-va; ácido nucleico, plásmido y célula hospedera que la comprenden; pttv infeccioso no virulento; vacuna. CL2014003561A1 (es)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US23583309P	2009-08-21	2009-08-21
US31651910P	2010-03-23	2010-03-23
US12/861,378 US9228242B2 (en)	2009-08-21	2010-08-23	Porcine torque teno virus vaccines and diagnosis

Publications (1)

Publication Number	Publication Date
CL2014003561A1 true CL2014003561A1 (es)	2015-04-24

Family

ID=43605547

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
CL2012000452A CL2012000452A1 (es)	2009-08-21	2012-02-22	Acido nucleico infeccioso de virus torque teno porcino (pttv), que comprende secuencia que codifica un pttv infeccioso con una secuencia genomica de pttv 1a-va; acido nucleico, plasmido y celula hospedera que la comprenden; pttv infeccioso no virulento; vacuna.
CL2014003563A CL2014003563A1 (es)	2009-08-21	2014-12-29	Acido nucleico infeccioso de virus torque teno porcino (pttv) que comprende secuencia que codifica un pttv infeccioso con una secuencia genómica de pttv 2c-va; acido nucleico, plásmido y célula hospedera que la comprenden; pttv infeccioso no virulento; vacuna
CL2014003561A CL2014003561A1 (es)	2009-08-21	2014-12-29	Ácido nucleico infeccioso de virus torque teno porcino (pttv) que comprende secuencia que codifica un pttv infeccioso con una secuencia genómica de pttv 1b-va; ácido nucleico, plásmido y célula hospedera que la comprenden; pttv infeccioso no virulento; vacuna.
CL2014003562A CL2014003562A1 (es)	2009-08-21	2014-12-29	Acido nucleico infeccioso de virus torque teno porcino (pttv) que comprende secuencia que codifica un pttv infeccioso con una secuencia genómica de pttv 2b-va; acido nucleico, plásmido y célula hospedera que la comprenden; pttv infeccioso no virulento; vacuna

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
CL2012000452A CL2012000452A1 (es)	2009-08-21	2012-02-22	Acido nucleico infeccioso de virus torque teno porcino (pttv), que comprende secuencia que codifica un pttv infeccioso con una secuencia genomica de pttv 1a-va; acido nucleico, plasmido y celula hospedera que la comprenden; pttv infeccioso no virulento; vacuna.
CL2014003563A CL2014003563A1 (es)	2009-08-21	2014-12-29	Acido nucleico infeccioso de virus torque teno porcino (pttv) que comprende secuencia que codifica un pttv infeccioso con una secuencia genómica de pttv 2c-va; acido nucleico, plásmido y célula hospedera que la comprenden; pttv infeccioso no virulento; vacuna

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
CL2014003562A CL2014003562A1 (es)	2009-08-21	2014-12-29	Acido nucleico infeccioso de virus torque teno porcino (pttv) que comprende secuencia que codifica un pttv infeccioso con una secuencia genómica de pttv 2b-va; acido nucleico, plásmido y célula hospedera que la comprenden; pttv infeccioso no virulento; vacuna

Country Status (20)

Country	Link
US (2)	US9228242B2 (es)
EP (2)	EP2851428B1 (es)
JP (3)	JP6002036B2 (es)
KR (3)	KR101640062B1 (es)
CN (2)	CN102712930B (es)
AU (1)	AU2010292848B2 (es)
BR (1)	BR112012003844B1 (es)
CA (1)	CA2771771C (es)
CL (4)	CL2012000452A1 (es)
CO (1)	CO6531416A2 (es)
ES (1)	ES2767781T3 (es)
HK (1)	HK1249111A1 (es)
IN (1)	IN2012DN02305A (es)
MX (1)	MX344015B (es)
PH (2)	PH12016502013A1 (es)
PL (1)	PL2851428T3 (es)
RU (1)	RU2553223C2 (es)
SG (1)	SG178512A1 (es)
WO (1)	WO2011031438A2 (es)
ZA (1)	ZA201201949B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3278122B2 (ja)	1993-06-11	2002-04-30	自動車電機工業株式会社	電磁継電器の製造方法
US9228242B2 (en)	2009-08-21	2016-01-05	Virginia Tech Intellectual Properties, Inc.	Porcine torque teno virus vaccines and diagnosis
EP2530170A1 (en) *	2011-05-31	2012-12-05	Intervet International BV	Torque Teno virus diagnostics
CN102590503B (zh) *	2012-01-20	2015-02-25	四川农业大学	一种猪细环病毒ⅱ型抗体间接阻断elisa检测试剂盒
CN103376317B (zh) *	2012-04-12	2015-11-18	徐超	不同疫苗适用性与经济性的现场判定方法
EP2653562A1 (en)	2012-04-20	2013-10-23	Institut Pasteur	Anellovirus genome quantification as a biomarker of immune suppression
CN103014056B (zh) *	2012-11-23	2014-12-10	广东海大畜牧兽医研究院有限公司	一种猪Ⅱ型细环病毒TTSuV2-ORF1截短蛋白的酵母表达及应用
CN102998453B (zh) *	2012-11-23	2014-10-08	广东海大畜牧兽医研究院有限公司	一种猪Ⅰ型细环病毒TTSuV1抗体间接ELISA诊断试剂盒及其制备方法
CN103235121B (zh) *	2013-03-18	2015-08-05	江苏省农业科学院	一种检测猪输血传播病毒2型抗体的间接elisa试剂盒
RU2744193C2 (ru) *	2015-10-16	2021-03-03	Канзас Стейт Юниверсити Рисерч Фаундейшн	Иммуногенные композиции для иммунизации свиней против цирковируса типа 3 и способы их получения и применения
CN107604098A (zh) *	2017-11-03	2018-01-19	福建省农业科学院畜牧兽医研究所	用于检测鸽TTV的EvaGreen实时荧光定量PCR引物及试剂盒
CN109061161B (zh) *	2018-11-14	2019-02-15	湖南省植物保护研究所	用于检测辣椒脉黄病毒的检测试剂盒及其应用
AU2021288320A1 (en) *	2020-06-12	2023-01-19	Flagship Pioneering Innovations V, Inc.	Tandem anellovirus constructs
KR20230036109A (ko) *	2020-06-12	2023-03-14	플래그쉽 파이어니어링 이노베이션스 브이, 인크.	바큘로바이러스 발현 시스템
MX2022016475A (es) *	2020-06-17	2023-04-11	Flagship Pioneering Innovations V Inc	Metodos de identificacion y caracterizacion de anellovirus y usos de los mismos.
TW202235622A (zh) *	2020-12-23	2022-09-16	美商旗艦先鋒創新公司	包裹rna之指環病毒(anellovirus)蛋白殼之活體外組裝

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1061377C (zh) *	1996-12-13	2001-01-31	中国预防医学科学院病毒学研究所	能用于包装重组腺病毒伴随病毒的单疱病毒载体及其用途
CN1704119A (zh) *	2004-05-28	2005-12-07	上海佳牧生物制品有限公司	猪细小病毒病油乳剂灭活疫苗
WO2008127279A2 (en) *	2006-10-05	2008-10-23	Cerebus Biologicals, Inc.	Methods for treating, preventing and diagnosing porcine ttv infection
CN102256997A (zh) *	2008-10-16	2011-11-23	美国辉瑞有限公司	细环病毒分离株和组合物
US9228242B2 (en)	2009-08-21	2016-01-05	Virginia Tech Intellectual Properties, Inc.	Porcine torque teno virus vaccines and diagnosis

2010
- 2010-08-23 US US12/861,378 patent/US9228242B2/en not_active Expired - Fee Related
- 2010-08-23 IN IN2305DEN2012 patent/IN2012DN02305A/en unknown
- 2010-08-23 PH PH1/2016/502013A patent/PH12016502013A1/en unknown
- 2010-08-23 EP EP14180718.0A patent/EP2851428B1/en not_active Not-in-force
- 2010-08-23 CA CA2771771A patent/CA2771771C/en not_active Expired - Fee Related
- 2010-08-23 PH PH1/2012/500359A patent/PH12012500359A1/en unknown
- 2010-08-23 SG SG2012011714A patent/SG178512A1/en unknown
- 2010-08-23 MX MX2012002273A patent/MX344015B/es active IP Right Grant
- 2010-08-23 JP JP2012525752A patent/JP6002036B2/ja not_active Expired - Fee Related
- 2010-08-23 RU RU2012110303/10A patent/RU2553223C2/ru active
- 2010-08-23 CN CN201080047299.6A patent/CN102712930B/zh not_active Expired - Fee Related
- 2010-08-23 KR KR1020127007322A patent/KR101640062B1/ko not_active Expired - Fee Related
- 2010-08-23 KR KR1020147026815A patent/KR101721090B1/ko not_active Expired - Fee Related
- 2010-08-23 CN CN201710468515.8A patent/CN107522775A/zh active Pending
- 2010-08-23 AU AU2010292848A patent/AU2010292848B2/en not_active Ceased
- 2010-08-23 BR BR112012003844-3A patent/BR112012003844B1/pt not_active IP Right Cessation
- 2010-08-23 WO PCT/US2010/046330 patent/WO2011031438A2/en not_active Ceased
- 2010-08-23 KR KR1020147023761A patent/KR20140110101A/ko not_active Withdrawn
- 2010-08-23 ES ES14180718T patent/ES2767781T3/es active Active
- 2010-08-23 PL PL14180718T patent/PL2851428T3/pl unknown
- 2010-08-23 EP EP10815817.1A patent/EP2467484A4/en not_active Ceased
2012
- 2012-02-22 CL CL2012000452A patent/CL2012000452A1/es unknown
- 2012-03-15 ZA ZA2012/01949A patent/ZA201201949B/en unknown
- 2012-03-21 CO CO12047889A patent/CO6531416A2/es unknown
2014
- 2014-12-29 CL CL2014003563A patent/CL2014003563A1/es unknown
- 2014-12-29 CL CL2014003561A patent/CL2014003561A1/es unknown
- 2014-12-29 CL CL2014003562A patent/CL2014003562A1/es unknown
2015
- 2015-08-06 JP JP2015155940A patent/JP6126176B2/ja not_active Expired - Fee Related
- 2015-11-19 US US14/946,384 patent/US9897605B2/en not_active Expired - Fee Related
2017
- 2017-04-10 JP JP2017077460A patent/JP2017171663A/ja active Pending
2018
- 2018-06-21 HK HK18107954.9A patent/HK1249111A1/zh unknown

Also Published As

Publication number	Publication date
KR20120063489A (ko)	2012-06-15
CN107522775A (zh)	2017-12-29
PH12012500359A1 (en)	2012-10-22
WO2011031438A9 (en)	2011-08-18
JP2013502229A (ja)	2013-01-24
HK1249111A1 (zh)	2018-10-26
ES2767781T3 (es)	2020-06-18
KR101640062B1 (ko)	2016-07-18
ZA201201949B (en)	2013-05-29
KR101721090B1 (ko)	2017-03-29
WO2011031438A2 (en)	2011-03-17
CA2771771A1 (en)	2011-03-17
KR20140110101A (ko)	2014-09-16
AU2010292848B2 (en)	2014-11-27
US9228242B2 (en)	2016-01-05
CN102712930A (zh)	2012-10-03
US20110045019A1 (en)	2011-02-24
CA2771771C (en)	2018-09-11
CL2012000452A1 (es)	2013-07-05
CO6531416A2 (es)	2012-09-28
EP2851428A3 (en)	2015-04-29
JP2017171663A (ja)	2017-09-28
CL2014003562A1 (es)	2015-04-24
AU2010292848A1 (en)	2012-04-12
CN102712930B (zh)	2017-06-13
PH12016502013A1 (en)	2023-02-27
EP2467484A4 (en)	2013-06-12
MX2012002273A (es)	2012-09-07
US20160216263A1 (en)	2016-07-28
SG178512A1 (en)	2012-03-29
EP2467484A2 (en)	2012-06-27
EP2851428A2 (en)	2015-03-25
RU2012110303A (ru)	2013-09-27
US9897605B2 (en)	2018-02-20
IN2012DN02305A (es)	2015-08-21
MX344015B (es)	2016-12-02
BR112012003844A2 (pt)	2016-11-16
EP2851428B1 (en)	2019-04-10
RU2553223C2 (ru)	2015-06-10
JP2015221819A (ja)	2015-12-10
BR112012003844B1 (pt)	2021-05-04
JP6126176B2 (ja)	2017-05-10
WO2011031438A3 (en)	2011-06-30
PL2851428T3 (pl)	2019-12-31
KR20140127903A (ko)	2014-11-04
JP6002036B2 (ja)	2016-10-05
CL2014003563A1 (es)	2015-04-17

Publication	Publication Date	Title
CL2014003561A1 (es)	2015-04-24	Ácido nucleico infeccioso de virus torque teno porcino (pttv) que comprende secuencia que codifica un pttv infeccioso con una secuencia genómica de pttv 1b-va; ácido nucleico, plásmido y célula hospedera que la comprenden; pttv infeccioso no virulento; vacuna.
WO2014052378A3 (en)	2014-10-02	Subunit immersion vaccines for fish
DK2519266T3 (da)	2017-11-06	Infektiøse DNA vacciner mod Chikungunya virus
BRPI0814459A2 (pt)	2014-10-21	Célula de inseto, método para produzir um vírion parvoviral recombinante em uma célula de inserto, e, construção de ácido nucleico.
MX2013010620A (es)	2013-12-06	Adenovirus de aves del serotipo 4 (fadv-4) no patogénico y vector viral del mismo.
BRPI0923448A2 (pt)	2018-10-09	vírus influenza rearranjado, composição antigênica de vírus influenza rearranjado, vacina, e, métodos para provocar uma resposta imune a pelo menos uma cepa pandêmica de vírus influenza em um indivíduo, para prevenir infecção de um indivíduo por um vírus influenza, e para preparar uma vacina.
BRPI0811499A2 (pt)	2014-10-14	Métodos para purificar um vírus ou antígeno viral, e para preparar uma vacina contra um vírus ou antígeno viral.
WO2010019262A3 (en)	2010-05-27	Polyvalent vaccine
BR112013016683A2 (pt)	2017-07-11	oligodesoxinucleotídeo não metilado imunoestimulatório, vetor, vacina para prevenir ou combater uma doença infecciosa, célula, e, método para a detecção de oligodesoxinucleotídeos imunoestimulatórios.
CL2008000249A1 (es)	2008-05-30	Uso de una molecula de acido nucleico que codifica al menos un polipeptido e2 del papilomavirus, un vector o una particula virica infecciosa que la comprenda para tratar una infeccion permanente por papilomavirus causada por al menos un papilomavirus
BRPI0810211A2 (pt)	2014-10-21	Citolisina dependente de colesterol mutante purficada, composição, vacina, método para vacinar um paciente, anticorpo monoclonal, ácido nucléico, e, célula hospedeira.
UA108902C2 (uk)	2015-06-25	Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування
ZA201306009B (en)	2015-03-25	Nucleic acid molecule encoding hepatitis b virus core protein and vaccine comprising the same
WO2009115917A3 (en)	2010-02-04	Improvements in preparation of influenza virus vaccine antigens
HK1197189A1 (en)	2015-01-09	Canine coronavirus vaccine
EP2576581A4 (en)	2015-04-15	RECOMBINANT RNA VIRUSES AND USES THEREOF
BR112013016503A2 (pt)	2018-05-22	composições e método de vacina de vírus da diarreia viral bovina tipo 1b.
WO2011014416A3 (en)	2011-05-19	High yield yellow fever virus strain with increased propagation in cells
WO2008045601A3 (en)	2008-08-07	Adenovirus-based genetic vaccines for biodefense
ECSP12012131A (es)	2013-02-28	Método, plasmideo y composición para inducir una respuesta inmune contra virus de la dengue basado en vacunas de adn y virus quiméricos
WO2012116253A3 (en)	2013-02-28	Recombinant mumps virus vaccine
WO2007082734A3 (en)	2007-10-04	Influenza vaccine
CL2015001803A1 (es)	2015-10-16	Composición inmunogénica que comprende cepas del virus del oeste del nilo muerto o inactivado o cualquier antígeno del mismo; y método para disminuir síntomas clínicos asociados a infección por dicho virus en animales (div. sol. n° 445-11)
WO2013052095A3 (en)	2013-06-06	Vaccine
AR067439A1 (es)	2009-10-14	Virus quimericos antigenicos de virus de encefalitis de st. louis/virus dengue tipo 4